greeksoup/ stock research

CME Group (CME) FY2024 results: revenue $6.1 billion, up 9.9% on the year

CME Group Inc. (CME) reported revenue of $6.1 billion for fiscal 2024, the year ended 31 December 2024, up 9.9% on the year before. Net income was $3.5 billion, up 9.3%, and diluted earnings per share $9.67. The figures are the company's own, from the 10-K it filed with the SEC on 27 February 2025.

Revenue
$6.1 billion
+9.9% on the year
FY2017FY2024
Operating margin
64.1%
61.6% a year earlier
FY2017FY2024
Net income
$3.5 billion
+9.3% on the year
FY2017FY2024
Diluted EPS
$9.67
+9.1% on the year
FY2017FY2024

this yearthe year beforeHover a bar for its figure.

The year in brief

The four quarters: Q1 FY2024 · Q2 FY2024 · Q3 FY2024 · Q4 FY2024

Income statement (profit and loss)

$ millionFY2024FY2023FY2022On the yearLast 8 years
Revenue6,1305,5795,019+9.9%
Operating income3,9323,4363,016+14.4%
Operating margin64.1%61.6%60.1%
Pre-tax income4,5414,1543,490+9.3%
Income tax1,016927799+9.5%
Effective tax rate22.4%22.3%22.9%
Net income3,5263,2262,691+9.3%
Net margin57.5%57.8%53.6%
Diluted EPS$9.67$8.86$7.40+9.1%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2024FY2023FY2022On the yearLast 8 years
Operating cash flow3,6903,4543,056+6.9%
Capital expenditure94.076.489.7+23.0%
Free cash flow3,5963,3772,966+6.5%
Free cash flow margin58.7%60.5%59.1%
Cash from investing-82.620.9-490
Cash from financing5,076-48,339-25,382
Depreciation and amortisation115126135-8.7%
Share-based compensation89.582.984.3+8.0%
Dividends paid3,5843,2362,634+10.8%
Dividend per share$10.40$8.50$8.50+22.4%
Diluted shares, weighted360m360m359m+0.1%

Balance sheet

$ millionFY2024FY2023FY2022On the yearLast 8 years
Shareholders' equity26,48726,73826,879-0.9%
Short-term borrowingsn/a0.016.0
Debt3,4283,4253,422+0.1%
Operating lease liabilities289344384-15.9%
Finance lease liabilities50.759.467.8-14.6%
Other liabilities107,19299,139143,407+8.1%
Total liabilities and equity137,447129,706174,176+6.0%
Fixed assets386410456-5.7%
Goodwill10,48710,49510,482-0.1%
Intangible assets2,8223,0503,270-7.5%
Investments11311296.0+1.3%
Trading assets10410184.5+2.9%
Cash and equivalents2,8922,9122,720-0.7%
Receivables573536483+7.0%
Other assets120,069112,090156,584+7.1%
Total assets137,447129,706174,176+6.0%

10-K for the year ended 31 December 2024, filed 27 February 2025: the filing.